Earnings Call · Q4 FY2021·2022-03-23

Q4 21EPS +1.64%·Rev n/aQ3 21EPS -56.13%·Rev n/aQ2 21EPS -4.08%·Rev n/aQ1 21EPS +6.34%·Rev n/a⚠ consensus missing

RELMADA THERAPEUTICS, INC. RLMD

Tim McCarthy — Investor Relations or Communications

Sergio Traversa — Chief Executive Officer

Maged Shenouda — Chief Financial Officer

0.0%1d on move date+1.3% vs SPY3d+10.4%5d+10.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RLMD calls or request research access.

More RLMD calls Browse calls Request research access